More
    Guided Solutions - Connecting Talent With Innovation/div>

    JenaValve wins FDA nod for Trilogy heart valve system

    JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system. Trilogy, a transcatheter heart valve (THV) system, won approval for the treatment of patients with symptomatic, severe aortic regurgitation (AR) at...

    JenaValve wins FDA nod for Trilogy heart valve system

    JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system. Trilogy, a transcatheter heart valve (THV) system, won approval for the...

    GE HealthCare completes $2.3B Intelerad acquisition

    GE HealthCare announced that it completed its previously announced $2.3 billion acquisition of Intelerad. Chicago-based GE HealthCare announced in November that it agreed to buy...

    Nia Therapeutics wins FDA breakthrough nod for neuromod

    Nia Therapeutics announced that it received FDA breakthrough device designation for its Smart Neurostimulation System (SNS). The device won the breakthrough nod for the treatment...

    Imperative Care secures $100M for stroke care tech commercialization

    Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million. New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

    VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

    Innovation

    Regulatory Approvals

    JenaValve wins FDA nod for Trilogy heart valve system

    JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system. Trilogy, a transcatheter heart valve (THV) system, won approval for the...

    GE HealthCare completes $2.3B Intelerad acquisition

    GE HealthCare announced that it completed its previously announced $2.3 billion acquisition of Intelerad. Chicago-based GE HealthCare announced in November that it agreed to buy...

    Nia Therapeutics wins FDA breakthrough nod for neuromod

    Nia Therapeutics announced that it received FDA breakthrough device designation for its Smart Neurostimulation System (SNS). The device won the breakthrough nod for the treatment...

    Imperative Care secures $100M for stroke care tech commercialization

    Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million. New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing...

    M&A

    Archives

    Latest articles